Synergic Renoprotective Effects of Combined ASC Therapy with RAAS Blockade in Experimental Advanced CKD

Global prevalence of chronic kidney disease (CKD) has increased considerably in the recent decades. Overactivity of the renin-angiotensin-aldosterone system (RAAS), associated to renal inflammation and fibrosis, contributes to its evolution. The treatments currently employed to control CKD progressi...

Descripción completa

Detalles Bibliográficos
Autores principales: Maires, Marina P. C., Pereira, Krislley R., Silva, Everidiene K. V. B., Souza, Victor H. R., Teles, Flavio, Barbosa, Paulyana F., Garnica, Margoth R., Ornellas, Felipe M., Noronha, Irene L., Fanelli, Camilla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975629/
https://www.ncbi.nlm.nih.gov/pubmed/35371263
http://dx.doi.org/10.1155/2022/5111782

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975629/
https://www.ncbi.nlm.nih.gov/pubmed/35371263
http://dx.doi.org/10.1155/2022/5111782

Ejemplares similares